LOSORDO DOUGLAS W 4
4 · CALADRIUS BIOSCIENCES, INC. · Filed Jan 15, 2020
Insider Transaction Report
Form 4
LOSORDO DOUGLAS W
Chief Medical Officer
Transactions
- Award
Common Stock
2020-01-13+19,000→ 135,197 total - Tax Payment
Common Stock
2020-01-13$3.28/sh−2,601$8,531→ 132,596 total - Award
Stock Options (Right to Buy)
2020-01-13+29,000→ 29,000 totalExercise: $3.28From: 2020-01-13Exp: 2030-01-13→ Common Stock (29,000 underlying) - Tax Payment
Common Stock
2020-01-14$3.38/sh−2,190$7,402→ 130,406 total
Footnotes (3)
- [F1]Represents 19,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
- [F2]Includes 25,575 unvested restricted stock awards.
- [F3]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.